Empagliflozin, a selective SGLT2 inhibitor, inhibits cardiovascular injury and cognitive impairment in mice with type 2 diabetes mellitus
Year: 2016
Type: article
Author: 林, 博文
Language: Japanese
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7125355955
